Patients dying in cancer drugs wait: MA

IV in hand: cancer drugs
Australian cancer patients don’t have time to wait for access to new cancer drugs, says Medicines Australia. In its submission to the Senate Inquiry into the availability of new, innovative and specialist cancer drugs in Australia, Medicines Australia says the time lag between the Therapeutic Goods Administration’s approval and listing on the PBS is costing

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Managing high pressure with CMs: Braun
Next Chondroitin use confirmed in Cochrane Review